A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...

Researchers examined the relationship between a diet that provokes inflammation and the risk for irritable bowel syndrome.

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel ...

Risk factors for IBS may include HIV infection; however, additional large-scale studies are necessary to draw sound conclusions.

Recent research into the role of gluten and wheat in triggering symptoms for people with Irritable Bowel Syndrome (IBS) ...

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

Cite this: Development and Psychometric Testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) - Medscape - May 03, 2007. Authors' contributions: MB has substantial ...

Functional abdominal pain (FAP) and irritable bowel syndrome (IBS) are among the most commonly diagnosed medical problems in pediatrics. Symptom-based Rome III criteria for FAP and IBS have been ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

chu-nice.fr Objective To determine the role of colonic barrier defects and low-grade inflammation in irritable bowel syndrome (IBS)-like symptoms in quiescent inflammatory bowel disease (IBD). Design ...

Inflammatory bowel disease pain is the result of either ulcerative colitis or Crohn's disease. Both conditions lead to abdominal pain that can be accompanied by diarrhea. However, the locations where ...